SEC Form D · filed September 23, 2022
NovaBay Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Yongxiang (Sean) Zheng · EMERYVILLE, CADirectorSwan E. Sit · EMERYVILLE, CADirectorYenyou (Jeff) E. Zheng · EMERYVILLE, CADirectorAndrew M. Jones · EMERYVILLE, CAExecPaul E. Freiman · EMERYVILLE, CADirectorMijia (Bob) Wu · EMERYVILLE, CADirectorAudrey M. Kunin · KANSAS CITY, MOExec · DirectorJulie Garlikov · EMERYVILLE, CADirectorJustin M. Hall · EMERYVILLE, CAExec · DirectorJeffrey M. Kunin · KANSAS CITY, MOExecBhavika Vyas · New York, NYDirectorSuzanne Tavill · Sydney, Channel IslandsDirectorJill M. Smith · Huxley, IAExec · DirectorSeth M. Tjaden · Huxley, IAExecJorge E. Bartolome · Chapel Hill, NCDirectorCato Partners GP, LLC · New York, NYDirectorStephen E. Butts · Chapel Hill, NCDirectorWilliam Burns · McKinney, TXExec · DirectorJp A. Paquin · New York, NYDirectorSean Stiefel · Redondo Beach, CAExecCato Partners Management, LLC · New York, NYDirectorBenjamin Gomez · Chapel Hill, NCDirectorSteven M. Diedrich · Waco, TXDirectorJerry L. Whitmire · Tempe, AZDirectorvan Biema Value Partners, LLC · New York, NYDirectorvan Biema & Company, LLC · New York, NYExecJeff Siegel · Huntsville, UTExec · DirectorAnupkumar M. Shetty, M.D · Dallas, TXExec · DirectorJoris M. Schuller, Jr., M.D · Dallas, TXExecHugh D. Evans · NEW YORK, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗